Scientists find a simple daily routine linked to less pain and depression

A consistent daily routine may do more for your health than you realize. Researchers at the University of Missouri have found that older adults who follow regular daily schedules tend to experience less physical pain and fewer symptoms of depression, even when they struggle to get a good night’s sleep.

The findings suggest that everyday habits, such as waking up, eating meals, socializing, and going to bed at consistent times, may play an important role in physical and mental well-being. By helping the body maintain its natural internal clock, a predictable routine could offer health benefits that extend beyond improved sleep.

The discovery could be especially important for older adults, who frequently experience sleep difficulties. According to the National Council on Aging, roughly half of adults age 60 and older report symptoms of insomnia, a condition that can make it difficult to fall asleep, stay asleep, or get restful sleep.

Daily Routines Linked to Less Pain and Depression

To investigate the relationship between sleep, daily habits, and overall health, Eunjin Tracy, an assistant professor in the College of Education and Human Development at the University of Missouri, examined survey responses from 67 older adults. Among the participants, 37 reported experiencing insomnia.

As researchers expected, those with insomnia generally reported more physical pain and higher levels of depression than participants without the condition. However, another pattern emerged when Tracy examined their daily routines.

Participants who maintained more consistent schedules tended to report less pain and fewer depressive symptoms, regardless of their sleep quality. This suggests that keeping regular daily habits may be associated with better health even when sleep problems persist.

“Regardless of sleep quality, those who reported having a regular daily routine had lower levels of physical pain and less depression compared to those without a daily routine,” Tracy said. “If we are consistent with when we wake up, eat, work or study, interact with others and go to bed, those time cues help synchronize our internal body clocks. Over the long term, that seems to be linked with improved health outcomes.”

Why Your Body’s Internal Clock Matters

One possible explanation involves the circadian rhythm, the body’s natural 24-hour timing system. This internal clock helps coordinate when we feel awake or sleepy and influences numerous biological processes, including hormone activity, metabolism, and mood.

Rather than operating independently of our surroundings, the circadian system responds to signals that help it keep time. Light and darkness are especially important, but regular activities such as eating, working, interacting with others, and sleeping can also provide timing cues.

When these signals follow a predictable pattern, they help keep the body’s biological rhythms aligned. Irregular schedules, on the other hand, can interfere with that coordination.

“When we regulate our circadian rhythm well, our bodies function well, but if it gets too distracted, our bodies don’t function as well,” Tracy said.

Although the study did not establish that regular routines directly reduce pain or depression, the findings point to circadian regulation as one possible explanation for the connection.

The Hidden Effects of Social Jet Lag

Even relatively small changes in daily schedules may disrupt the body’s internal clock. One common example is social jet lag, which occurs when a person’s sleep schedule shifts between workdays and days off.

Someone who wakes up early throughout the week but stays up late and sleeps in on weekends may experience this mismatch. The resulting disruption resembles some of the effects of traveling across time zones, even though the person has never left home.

Tracy suggests that maintaining reasonably consistent schedules throughout the entire week, including weekends, may help limit these disruptions and support healthier circadian rhythms.

“As someone who wakes up and goes to bed at the same time every day, I think a daily routine can be helpful for people of all ages across their lifespan,” Tracy said. “There is growing awareness about the concept of social jet lag — waking up and going to bed at different times on weekends compared to weekdays — and the disruptions it causes to our circadian rhythm, so hopefully this research helps more people consider the health benefits of a daily routine. Since one-third of our lives will be spent sleeping, I think health and well-being research should be looked at holistically from a 24-hour perspective and not just focus on when we are awake.”

A Simple Habit With Potential Health Benefits

The research highlights an aspect of healthy living that can be easy to overlook. While getting enough quality sleep remains important, the consistency of activities throughout the day may also be connected to how people feel physically and emotionally.

Because the study relied on survey data from a relatively small group of older adults, it cannot prove that adopting a regular routine will relieve pain or depression. Larger studies would be needed to establish whether changing daily schedules directly improves these outcomes.

Still, the findings suggest that a predictable daily routine may be a useful component of a broader approach to health, particularly for people experiencing insomnia.

For older adults and potentially people of other ages, simple habits such as maintaining regular waking times, eating meals on a consistent schedule, and limiting major changes in weekend sleep patterns may help support the body’s natural rhythms.

The study, “Behavioral-social rhythms and insomnia symptoms: associations with pain, body mass index, and depressive symptoms among older adults,” was published in the Journal of Behavioral Medicine.

Share Button

A new fiber supplement could help millions suffering from irritable bowel syndrome

A specially designed fiber supplement may offer a promising new way to improve gut health for millions of people with irritable bowel syndrome (IBS). Researchers at Edith Cowan University (ECU) have developed and tested a fiber combination that supports beneficial gut bacteria without making common digestive symptoms worse.

The research team at ECU’s Nutrition and Health Innovation Research Institute (NHIRI) found that the supplement, called ur gut®, improved gut health in people with IBS without increasing abdominal pain, bloating, diarrhea, or constipation.

IBS affects people around the world, including nearly 11 percent of Australians. Although its exact cause remains unclear, stress, infections, and certain medications may contribute to the condition. Symptoms can also become worse because of particular foods, inadequate sleep, psychological stress, hormonal changes, and lifestyle factors.

Why Common IBS Diets Can Affect Gut Health

People with IBS are frequently advised to follow a low-FODMAP diet, which limits certain carbohydrates that are easily fermented by gut bacteria. Although this approach can help control uncomfortable symptoms, restricting these foods may also have unintended consequences for the gut microbiome.

“For years we’ve known that a diet low in Fermentable Oligosaccharides, Disaccharides, Monesaccharides and Polyols (FODMAPs) can relieve symptoms, but they can also reduce beneficial gut bacteria and negatively impact fiber intake over time,” lead author Dr. Tina Yan said.

“We wanted to find a way to build better gut health while following a low-FODMAP diet.”

The new findings suggest that a carefully formulated fiber supplement could help address this problem, allowing people with IBS to support a healthier gut microbiome while continuing to manage their symptoms through dietary changes.

How the New Fiber Blend Works

The researchers attribute the supplement’s promising effects to its combination of two ingredients: resistant starch and psyllium husk.

Psyllium appears to slow the breakdown of resistant starch by gut bacteria, allowing more of it to reach deeper sections of the colon before fermentation occurs. This process may increase the production of beneficial compounds that support intestinal health.

Ordinarily, fermentable fiber can be challenging for people with IBS because bacterial fermentation can produce excess gas and increase digestive discomfort. The new formulation appears to offer a way to obtain the benefits of fermentation without aggravating these symptoms.

“Traditionally, fermentable fibers can be difficult for people with IBS because they can increase gas production and discomfort,” Dr. Yan said.

“What’s exciting about this study is that participants maintained stable symptoms while showing meaningful improvements in their gut microbiota as well as in their gut-related anxiety.”

Significant Changes in Gut Bacteria and Anxiety

The researchers observed substantial shifts in the composition of participants’ gut bacteria during the intervention. These changes were particularly notable because they occurred over a relatively short period.

“Changes of this magnitude are rarely seen with such a short intervention,” ur gut® co-creator Professor Amanda Devine said.

“The study demonstrated that our targeted dietary fiber blend positively reshaped the gut microbiome in people with IBS following a low-FODMAP diet, supporting beneficial bacteria linked to gut and mental health. This was great to see.”

Alongside improvements in gut bacteria, participants also experienced reductions in gut-related anxiety. These findings suggest that the supplement’s potential benefits may extend beyond changes in the digestive system, although further research will be needed to establish its broader effects.

A New Approach to Managing Irritable Bowel Syndrome

The researchers believe their findings could help shift IBS care toward improving the underlying health of the gut rather than focusing exclusively on avoiding foods that cause discomfort.

“For many people with IBS, success has traditionally meant simply avoiding certain foods,” ur gut® co-creator Associate Professor Claus Christophersen said.

“Our findings suggest we may also be able to actively rebuild gut health and the microbiome while not making IBS symptoms worse. That’s an important step forward.”

By demonstrating that beneficial gut bacteria can be supported without increasing IBS symptoms, the study points toward new dietary strategies that could complement existing treatments.

The ur gut® supplement is already available for purchase. The research team has also created a cookbook featuring recipes designed to help people incorporate the supplement into a healthy diet.

The study, “Dietary fibre blend improves gut health in patients with irritable bowel syndrome following a low FODMAP diet: a randomised, double-blind control trial,” was published online in the European Journal of Nutrition.

Share Button

Woman with terminal cancer gets dream wedding on hospital ward

Maggie Heginbothom thanked the staff after a “dream” ceremony was arranged two days after her partner proposed.

Share Button

‘I cycled across America in memory of my wife – I know she’s proud of me’

Declan Faulkner cycled 3,800 miles from Portland, Oregon, to Portland, Maine, as a tribute to his late wife Patrina.

Share Button

Yale scientists reveal what really slows aging and what doesn’t

A growing body of research suggests that aging may be more flexible than once believed. Now, scientists at Yale have taken an important step toward identifying which treatments can actually influence biological aging and which ones show little measurable benefit.

Their findings suggest that certain prescription medications and lifestyle changes can reduce biological age as measured by DNA-based blood tests. Popular over-the-counter supplements examined in the research, however, showed little evidence of producing the same effects.

The findings, published in Nature Medicine, could help scientists evaluate anti-aging treatments more effectively, although researchers emphasize that changes in biological age markers do not necessarily mean people will live longer or avoid age-related diseases.

From Fighting Cancer to Understanding Aging

When Raghav Sehgal began graduate school at Yale several years ago, he planned to use advanced computer science techniques to investigate cancer. His background in engineering and experience launching a computational biology startup had given him a strong foundation for that work.

However, a question from his Ph.D. adviser at the Yale School of Medicine changed his research direction. Rather than focusing on individual diseases such as cancer or cardiovascular disease, why not investigate the aging process that contributes to their development?

“That put me on a different path,” said Sehgal, now an associate research scientist in psychiatry who specializes in computational biology and bioinformatics. “As researchers, we have a long way to go in understanding the aging process and whether the steps we take to manage it really work.”

Sehgal now studies the biological mechanisms behind human aging, how scientists can measure those changes, and why getting older increases the likelihood of conditions such as cancer, diabetes, and dementia. His work also explores whether interventions might reverse certain aspects of biological aging, even if eliminating aging itself remains beyond reach.

New DNA Tests Reveal Which Anti-Aging Treatments Work

Sehgal is the lead author of the new study, which was conducted in the laboratory of Albert Higgins-Chen, an assistant professor of psychiatry at the Yale School of Medicine. The research team set out to determine which existing approaches to slowing aging produce changes that can be reliably measured.

Their analysis found encouraging results for certain medications and lifestyle interventions. In contrast, the over-the-counter supplements included in the study generally failed to produce meaningful reductions in biological age.

The project involved the entire Higgins-Chen laboratory, including Daniel Borrus, Jenel F. Armstrong, John Gonzalez, Jessica Kasamoto, and Yaroslav Markov.

“For the first time we’ve shown that certain therapies have measurable impacts,” said Sehgal. “This wasn’t previously possible, because we didn’t have enough data to say these biomarkers are consistently responsive to these interventions.”

Biomarkers provide measurable information about what is happening inside the body. In aging research, they can help estimate a person’s biological or functional age, which may differ from their chronological age.

How Scientists Measure Biological Age

To investigate whether treatments could influence aging, the Yale team relied primarily on blood-based measurements called epigenetic clocks.

These tools analyze chemical patterns attached to DNA, particularly methyl groups (basic chemical structures that act like tags). Previous research has shown that these chemical markers change as people grow older. Some interventions may reverse certain age-associated patterns, and computer algorithms use those changes to estimate a person’s biological age.

The researchers brought together findings from 51 clinical studies investigating different anti-aging strategies. These ranged from dietary supplements and medications to lifestyle changes and medical procedures.

Across those studies, the team examined more than 110 DNA methylation biomarkers (including 16 major epigenetic clocks). By comparing measurements taken before and after interventions, they could evaluate which approaches were associated with reductions in biological age.

“What we did was pretty unique,” Sehgal said. “We already know that certain things might prolong health span and lifespan. There is data from retrospective analysis as well as from animal models. We took all that knowledge along with the real-world clinical studies to identify which interventions in humans were slowing down aging across the board in these known biomarkers.”

Which Anti-Aging Treatments Showed the Best Results?

The researchers divided the interventions into four main groups: prescription drugs, lifestyle modifications, over-the-counter supplements, and medical procedures.

One of the clearest findings involved diet and exercise. Combining regular physical activity with a healthy eating plan consistently reduced epigenetic age. The dietary approaches examined included Mediterranean, low-fat, and low-carb diets.

The strongest reductions in biological age markers were associated with certain pharmaceutical treatments. These included metformin and semaglutide, prescription medications used to manage metabolic conditions and body weight, as well as anti-TNF therapies that target a protein involved in the body’s inflammatory response.

(TNF, or tumor necrosis factor, is an immune-system protein that helps fight inflammation-related injury.)

The findings were less encouraging for over-the-counter supplements and some medical procedures. In the studies examined, these approaches did not produce measurable reductions in epigenetic age.

The researchers also discovered that newer biological age clocks performed better than older versions. Another important finding was that people living with diseases generally experienced larger changes in their aging biomarkers than healthy participants.

Could DNA Blood Tests Transform Anti-Aging Research?

According to Sehgal, the next priority is to test these findings in larger, more diverse populations. This would help researchers determine how consistently different treatments influence biological aging across people with different health conditions and backgrounds.

The improved blood tests could also dramatically shorten the time needed to evaluate potential anti-aging therapies.

“If these new biomarkers are eventually validated to predict long-term health, scientists will be able to evaluate anti-aging therapies much faster,” he added. “Instead of waiting decades for evidence from clinical trials, we’ll be able to see which interventions are effective and in which people in a few years or even months.”

That possibility could represent a major advance for aging research. Instead of relying entirely on clinical studies that follow participants for decades, scientists might eventually use validated biological age measurements to identify promising treatments much earlier.

However, senior author Higgins-Chen stressed that scientists must be careful about interpreting what changes in aging biomarkers actually mean.

“We have developed a rigorous, systematic approach to evaluating and comparing how biomarkers change across a wide variety of interventions, and that is a critical step in the right direction,” he said. “However, the true meaning of that change must be fully understood.”

Important Questions About Slowing Aging Remain

Although the results are promising, several major questions remain unanswered.

For example, researchers still need to establish whether changes in biological age are directly caused by a treatment or influenced by other factors that were not accounted for. They also need to understand how quickly those changes occur, whether they persist after treatment ends, and which biological processes produce them.

Most importantly, scientists have not yet established whether lowering epigenetic age leads to meaningful improvements in long-term health.

“And most importantly – what does the change mean for our long-term risk of age-related disease and functional decline?” Higgins-Chen said.

Further investigations into these questions are underway, with additional studies led by Borrus, Armstrong, and Grace Zou.

The Higgins-Chen laboratory is also affiliated with Yale’s Department of Pathology, the Computational Biology and Bioinformatics Program, and the Y-Age Yale Center for Research on Aging.

What Appears to Work Against Biological Aging?

Based on the improved DNA-based blood tests, the Yale researchers identified two particularly promising approaches for reducing biological age markers:

  • Prescription medications: Drugs used for metabolic regulation and weight management, including metformin and semaglutide, were among the treatments associated with the strongest reductions in biological age.
  • Healthy eating combined with exercise: Regular physical activity paired with nutritious diets, including Mediterranean, low-fat, and low-carb eating plans, consistently produced favorable changes in aging biomarkers.

The analysis also identified benefits from certain anti-TNF medications, while the tested over-the-counter supplements and some medical procedures showed little measurable effect.

These results provide a clearer picture of which interventions may influence biological aging. However, more research is needed to confirm the findings and determine whether reductions in biological age markers ultimately translate into fewer age-related diseases, better health, or longer lives.

Share Button

‘I felt awful wearing my school uniform because of how I looked’

Charlie is one of 85 people in Northern Ireland who are waiting for surgery for pectus conditions

Share Button

Are you affected by the Microsoft outage?

A Microsoft outage has affected services including Teams, Outlook and AI software Copilot.

Share Button

Scientists discover a hidden danger of viral infections that vaccines may prevent

Vaccines may do more than protect people from the immediate effects of a viral infection. New research suggests they could also help prevent lasting damage to the immune system that remains even after the virus has disappeared.

Scientists at Pompeu Fabra University discovered that mice recovering from an acute viral infection experienced prolonged problems with their immune defenses. Although the animals had successfully fought off the virus, their immune systems remained impaired, making it harder to respond to new threats. Remarkably, mice vaccinated before infection did not develop these problems, suggesting that vaccination may provide an additional layer of protection beyond preventing illness.

Most people think of common viral infections, such as colds or stomach viruses, as temporary illnesses. A virus enters the body, multiplies, causes symptoms, and is eventually brought under control by the immune system. Once symptoms disappear, recovery is generally considered complete. The immune response also creates protection against future encounters with the same virus.

But what if the immune system continues to experience harmful effects long after the infection appears to be over?

Viral Infections Can Leave Lasting Immune Damage

Researchers from Pompeu Fabra University’s Infection Biology Laboratory investigated this possibility in a study published in Cell Death & Disease.

Using mice with acute viral infections, the team examined what happened to their immune systems after the animals had recovered. They found that eliminating the virus did not necessarily restore normal immune function. Instead, the infection left behind changes that persisted well beyond the initial illness.

According to Andreas Meyerhans, an ICREA research professor at UPF, who led the research, “there is a general perception that an acute viral infection is a relatively minor and transient event: once the virus is controlled and the symptoms have resolved, the body has fully recovered and is back to normal. But this view may underestimate consequences that are not immediately visible and can persist long after the infection itself has resolved.”

The researchers traced these lingering effects to significant changes in the spleen, an organ that plays an important role in coordinating immune defenses. As the immune system fought to eliminate the virus, the spleen developed fibrosis, a condition involving the buildup of scar-like tissue. The arrangement and positioning of immune cells within the organ also became disrupted.

These structural changes interfered with the interactions between immune cells that are necessary to activate T cells. These specialized cells are essential to adaptive immunity because they help recognize and destroy infected cells.

As a result, the mice remained less capable of launching effective immune responses when exposed to new challenges. Even though the original infection had been brought under control, their immune defenses continued to function poorly.

“The infection can be controlled, but that does not necessarily mean that the host has fully recovered,” says Dr. Paula Cebollada Rica, first author of the study. “Our findings show that the immune-related consequences of an acute viral infection can persist beyond the period in which the virus is detectable, leaving the animals in an immunocompromised state.”

Vaccination Prevented Lasting Immune System Damage

After identifying these long-term effects, the scientists investigated whether they could be avoided. They focused on vaccination, which prepares the immune system to recognize and fight a pathogen before an infection occurs.

The results revealed a striking difference between vaccinated and unvaccinated animals. Mice that received vaccination before infection did not develop the spleen damage or immune dysfunction seen in the other group.

Their spleens maintained their normal structure, and their T cells continued to function at levels comparable to those of mice that had never been infected.

This finding suggests that vaccination can protect the immune system itself from some of the harmful consequences of fighting a viral infection. In the mouse model, vaccination not only protected against the disease caused by the virus but also preserved the animals’ ability to respond to future immune challenges.

“Vaccinated animals did not experience T-cell dysfunction or splenic alterations after recovering from an acute viral infection. This means that vaccination not only prevented the disease resulting from the acute infection but also preserved the immune system’s ability to cope with new challenges,” Cebollada Rica explains.

A Hidden Benefit of Vaccines With Public Health Implications

The findings broaden the potential benefits of vaccination by highlighting a form of protection that may not be immediately apparent. Beyond reducing the immediate effects of an infection, vaccines may also help prevent persistent changes that weaken immune defenses.

Although these results were obtained in mice and do not establish that the same effects occur in humans, they raise important questions about how viral infections influence long-term immune health and how vaccination might help protect it.

The research also comes at a time when vaccination policies and infectious disease prevention efforts are increasingly influenced by political decisions. The researchers emphasize the importance of scientific evidence in understanding the full consequences of infections, particularly when policy choices can undermine coordinated efforts to prevent infectious diseases.

Understanding the broader benefits of vaccination could therefore influence not only medical care but also how public health officials explain the value of vaccines to the public.

“The benefits of vaccination highlighted by this research are important not only for healthcare, but also for how we communicate the value of vaccination to the population at large,” Meyerhans states. “It is important that people are aware of the broader protection that vaccination can provide and continue to trust in vaccines as one of the most effective tools to prevent diseases. Put simply, vaccines provide strong health benefits at a relatively low cost to society.”

Share Button

GPs, police and pharmacies among UK services affected by Microsoft outage

Major airports and intelligence services are unaffected while the government is assessing the impact on its services.

Share Button

Stopping statins after 70 may be safer than expected, but there’s a catch

A major new study suggests that many adults age 70 and older who have never experienced a heart attack or stroke may be able to stop taking statins without substantially increasing their short-term cardiovascular risks. However, the findings also point to a possible increase in risk over a longer period, making the decision more complicated than it initially appears.

The independent, preliminary research was presented at the American Heart Association’s Scientific Sessions 2026, held November 6 through 9 in Chicago. The annual conference brings together cardiovascular researchers and healthcare professionals from around the world to share scientific discoveries, emerging evidence, and advances in clinical care.

An estimated 25% of American adults have elevated levels of low-density lipoprotein-cholesterol (LDL-C), commonly called “bad cholesterol.” When too much LDL cholesterol accumulates in the arteries, it can restrict blood flow and contribute to heart attacks and strokes. Statins are widely prescribed to lower cholesterol and reduce these risks, including in people who have never experienced a cardiovascular event. This preventive approach remains a central part of the American Heart Association’s 2026 joint guideline on dyslipidemia.

Do Older Adults Need to Keep Taking Statins?

Although statins are an established treatment for reducing cardiovascular risk, questions remain about how much benefit they provide when people reach their 70s and beyond, particularly if they have never had a heart attack or stroke.

“While the Association’s recent joint guideline recommends lifestyle and potentially medication for people with high LDL-C at younger ages to reduce the risk of heart attack and stroke, recent studies question the health benefits of continuing statins in the later decades of life,” said study author Rita F. Redberg, M.D., M.Sc., FAHA, professor of cardiology and the Araxe Vilensky Endowed Chair in Cardiology at the University of California, San Francisco School of Medicine. “A few previous studies assessed the safety of discontinuing statins for primary prevention at age 70 and later, and they found no difference in mortality. One study suggested quality of life improvements after stopping statins. Whether it is safe to discontinue statins to prevent a first CVD event in the elderly remained unclear and the question we explored in our study.”

To investigate, researchers enrolled nearly 1,900 adults aged 70 and older who were taking statins specifically to prevent a first cardiovascular event. Every participant also had at least two chronic medical conditions, such as a history of cancer or lung disease.

Participants were divided into two groups. One group stopped taking statins, while the other continued their prescribed treatment. Researchers tracked their health for approximately two years, with additional follow-up extending as long as four years. They examined rates of heart attack, stroke, and death, along with changes in quality of life, muscle pain, falls, and muscle wasting (known as sarcopenia).

What Happened When Older Adults Stopped Statins?

The initial findings were largely reassuring. After approximately two years, participants who stopped taking statins did not experience a statistically significant increase in heart attacks, strokes, or deaths compared with those who remained on the medications.

Stopping treatment also did not produce measurable improvements in the other outcomes researchers examined. Quality of life, muscle discomfort, falls, and muscle wasting were similar in both groups.

There was, however, a small difference in cardiovascular outcomes. Over the first two years, the results indicated approximately one additional cardiovascular event for every 40 people who discontinued statins compared with those who continued treatment.

The longer follow-up revealed a more concerning pattern. Over a period of up to four years, 12.7% of participants who stopped statins experienced a heart attack, stroke, or death, compared with 9.2% of those who kept taking the medications.

Longer Follow-Up Reveals a Potential Risk

Redberg explained that the higher rate of serious outcomes during the four-year follow-up represents a new finding in research on statin discontinuation among older adults. She suggested that the difference may have emerged because this trial included more participants and tracked them for a longer period than earlier studies.

These results complicate the question of whether older adults should continue cholesterol treatment indefinitely. While the findings suggest that stopping statins may be a reasonable option for many people in this age group, they also indicate that remaining on treatment could offer some protection over time.

“This small, increased risk of cardiovascular events means that one cannot make a general recommendation about stopping statins in this patient population,” she said. “There should be shared decision-making between the patient and the healthcare professional to know if it is appropriate for an individual to discontinue the medication. In general, however, discontinuation is safe for most people who are in this age group and without a previous CVD event.”

Study Design and Important Limitations

The trial involved 1,880 participants aged 70 and older (average age of 77; 53% men, and 47% women), all of whom had at least two chronic health conditions. Individuals with established cardiovascular disease or a previous cardiovascular event were not eligible to participate.

Researchers conducted the study between November 2021 and April 2026 across 24 medical centers in Switzerland, France, and the Netherlands. Of the participants, 938 were assigned to discontinue statins, while 942 were assigned to continue taking their medications.

Throughout the trial and subsequent follow-up, researchers recorded heart attacks, acute ischemic strokes, and deaths from any cause. Participants also completed surveys assessing their overall quality of life, muscle pain, falls, and sarcopenia.

One limitation was that some participants did not remain in their originally assigned groups. Some people instructed to stop statins eventually resumed treatment, while others assigned to continue taking statins stopped using them. Altogether, approximately 14% of participants switched from their assigned treatment approach during the study.

To determine whether these changes affected the findings, the researchers performed several additional statistical analyses. The results remained unchanged.

Taken together, the findings suggest that discontinuing statins may be an option for many adults over 70 who have not previously experienced cardiovascular disease, especially when considering outcomes over the first two years. However, the higher rate of heart attacks, strokes, and deaths during longer follow-up underscores why stopping treatment should be an individualized decision made with a healthcare professional rather than a general recommendation for all older adults.

Share Button